Two Paths for New Tests

Paul Radensky explained that new market-based pricing requirements for clinical laboratories’ advanced testing Medicare reimbursement will build upon the work labs already do to get contracts with private payers. “The idea is that if you convince a private payer to agree to a contract, they must feel it’s valuable to their beneficiaries, and the rate would demonstrate that sense of value,” Mr. Radensky said. “This will mean that Medicare will reflect at least the value that private payers see.” Read the full article